Interindividual variation in carcinogen metabolism and bladder cancer risk.

Abstract excerpt

Epidemiological studies indicate that subjects of the genetically based slow acetylator phenotype may be at higher risk for bladder cancer than fast acetylators, particularly when they are exposed to carcinogenic arylamines: N-acetylation is a detoxification step in the metabolism of some arylamines. We describe two collaborative studies on tobacco smoking, in which markers of internal dose (arylamine-hemoglobin...

Topics

Share this publication in a Topic to start or enrich a Post.

• Share to Acetylation
• Share to Carcinogens
• Share to Dose-Response Relationship, Drug